Should you trade pfizer stock for shares in zoetis

Information contained on this page is provided by an independent third-party content provider.

Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases franklyinc. Lined up for evaluation this morning are the following four stocks: PFE , Zoetis Inc. ZTS , Mallinckrodt PLC NYSE: MNK , and Patheon N.

Register now and get full and free access to our downloadable research reports on these stocks at:. On Wednesday, shares in New York headquartered Pfizer Inc. The Company's shares are trading below their day moving average by 3.

Should You Trade Pfizer Stock for Shares in Zoetis? -- The Motley Fool

Furthermore, shares of Pfizer, which discovers, develops, manufactures, and sells healthcare products worldwide, have a Relative Strength Index RSI of On May 16 th , , research firm Citigroup downgraded the Company's stock rating from 'Neutral' to 'Sell'.

On May 17 th , , Pfizer announced it will present more than 50 abstracts, involving more than 15 clinical-stage assets across solid and hematologic tumors and 12 mechanisms of action, at the 53 rd Annual Meeting of the American Society of Clinical Oncology in Chicago from June 02 nd , , to June 06 th , New data will be featured in nine, oral presentations from company-sponsored clinical trials.

Should You Trade Pfizer Inc. (PFE) Stock for Shares in Zoetis Inc (ZTS)? - Insider Monkey

Access our complete research report on PFE for free at:. Parsippany, New Jersey headquartered Zoetis Inc. A total volume of 3. The Company's shares have gained The stock is trading above its day and day moving averages by Furthermore, shares of Zoetis, which engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the US and internationally, have an RSI of The dividend is to be paid on Friday, September 01 st , , to holders of record on Thursday, June 15 th , The complimentary research report on ZTS can be downloaded at:.

At the close of trading on Wednesday, shares in Chesterfield, the UK-based Mallinckrodt PLC rose 0. The stock recorded a trading volume of 2. The Company's shares are trading Moreover, shares of Mallinckrodt , which develops, manufactures, markets, and distributes branded and generic specialty pharmaceutical products and therapies in the US, Europe , the Middle East , Africa , and internationally, have an RSI of On May 23 rd , , Mallinckrodt confirmed enrollment of the first patient in its Phase-4 pilot study assessing the efficacy of H.

Register for free on Stock-Callers. Amsterdam, the Netherlands -based Patheon N. The stock has gained Additionally, shares of Patheon, which provides outsourced pharmaceutical development and manufacturing services, have an RSI of On May 08 th , , Patheon announced that it has completed an expansion project at its Greenville, NC manufacturing site.

The PDS Suites 1 and 2 provide 7,square-feet in GMP sterile manufacturing space. On May 16 th , , research firm Jefferies downgraded the Company's stock rating from 'Buy' to 'Hold'. Download your free research report on PTHN at:. Stock Callers SC produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks.

ZTS Stock Price - Zoetis Inc. Stock Quote (U.S.: NYSE) - MarketWatch

SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content in most cases not reviewed by a registered analyst , which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps.

Such sponsored content is outside the scope of procedures detailed below. The non-sponsored content contained herein has been prepared by a writer the "Author" and is fact checked and reviewed by a third party research service company the "Reviewer" represented by a credentialed financial analyst [for further information on analyst credentials, please email info stock-callers.

The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein.

Pfizer to spin off remaining Zoetis stake - MarketWatch

The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way. SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming.

No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not 1 guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or 2 warrant any results from use of the information.

The included information is subject to change without notice. This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever.

To download our report s , read our disclosures, or for more information, visit. CONTACT For any questions, inquiries, or comments reach out to us directly. Clyde Offices, Second Floor, 48 West George Street, Glasgow, U. For more information on this site, please read our Privacy Policy , Terms of Service , and Ad Choices.

Home News Local News Texas Headlines National International Weather Hurricane Tracker Weather Special: Hurricane Season Interactive Radar Weatherbug WeatherWarn Sports Local Sports Friday Football Fever Athlete of the Week Soccer Baseball Hockey College Sports News Football Basketball Sunrise Community Community Crossroads Medical Moment Community Calendar Crossroads Most Wanted Business Crossroads Law Gas Prices Affordable Care Act Tool Entertainment ABC FOX NBC This TV Antenna TV TV Schedule Contest Contact Us Advertise with Us Creative Services Employment Submit your Birthdays News Team FCC Public Inspection File-KAVU FCC Public Inspection Files-KVCT.

How These Healthcare Stocks are Faring? Register now and get full and free access to our downloadable research reports on these stocks at: Access our complete research report on PFE for free at: The complimentary research report on ZTS can be downloaded at: Download your free research report on PTHN at: SC has not been compensated; directly or indirectly; for producing or publishing this document.

To download our report s , read our disclosures, or for more information, visit http: Live DeTar Doppler Radar 7-Day Forecast.